OFM

Omega Fund Management Portfolio holdings

AUM $154M
This Quarter Return
+2.88%
1 Year Return
-32.78%
3 Year Return
+82.35%
5 Year Return
+29.08%
10 Year Return
+90.46%
AUM
$314M
AUM Growth
+$314M
Cap. Flow
-$3.63M
Cap. Flow %
-1.16%
Top 10 Hldgs %
94.94%
Holding
14
New
–
Increased
1
Reduced
2
Closed
–

Top Buys

1
REPL icon
Replimune Group
REPL
$3.15M

Top Sells

1
GOSS icon
Gossamer Bio
GOSS
$6.78M
2
PRVL
Prevail Therapeutics Inc. Common Stock
PRVL
$16

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
GOSS icon
1
Gossamer Bio
GOSS
$562M
$95.6M 30.44% 6,119,345 -433,771 -7% -$6.78M
REPL icon
2
Replimune Group
REPL
$422M
$76.1M 24.24% 5,323,455 +220,000 +4% +$3.15M
MORF
3
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$51M 16.22% 2,969,582 – –
TBIO
4
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$19.8M 6.32% 2,437,603 – –
IMUX icon
5
Immunic
IMUX
$80.9M
$13.3M 4.23% 1,371,494 – –
PRVL
6
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$10.6M 3.37% 668,907 -1 -0% -$16
PRTK
7
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$10.5M 3.34% 2,600,410 – –
EPIX icon
8
ESSA Pharma
EPIX
$11.4M
$9.4M 2.99% 1,709,848 – –
CDTX icon
9
Cidara Therapeutics
CDTX
$1.66B
$6.3M 2.01% 1,640,514 – –
FGEN icon
10
FibroGen
FGEN
$47.8M
$5.6M 1.78% 130,646 – –
TRVI icon
11
Trevi Therapeutics
TRVI
$883M
$4.74M 1.51% 1,263,408 – –
JNCE
12
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$4.63M 1.47% 529,965 – –
OBSV
13
DELISTED
ObsEva SA Ordinary Shares
OBSV
$3.82M 1.22% 999,364 – –
PVLA
14
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
$2.72M 0.87% 750,741 – –